Safe Administration of Ipilimumab, Pembrolizumab, and Nivolumab in a Patient With Metastatic Melanoma, Psoriasis, and a Previous Guillain–Barré Syndrome

Case Reports in Oncological Medicine- Egypt

doi 10.1155/2018/2783917

Full Text

Abstract

Available in

Categories

Oncology

Date

Authors

Publisher

Hindawi Limited

Related search

Panhypopituitarism in Metastatic Melanoma Patient Treated With Ipilimumab and Pembrolizumab

Journal of Cutaneous Immunology and Allergy
2019English

Severe Hemophagocytic Lymphohistiocytosis in a Melanoma Patient Treated With Ipilimumab + Nivolumab

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2018English

Overlap of Bickerstaff Encephalitis and Guillain-Barré Syndrome in a Patient With Systemic Lupus

Arquivos de Neuro-Psiquiatria
Biological PsychiatryNeurology
2009English

Paraneoplastic Hyperleucocytosis in a Melanoma Patient After Initiation of Ipilimumab and Nivolumab Combination Therapy

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2018English

Fatal Myocarditis and Rhabdomyositis in a Patient With Stage IV Melanoma Treated With Combined Ipilimumab and Nivolumab

Current Oncology
Oncology
2019English

Corrigendum to “Nivolumab and Ipilimumab in the Treatment of Metastatic Uveal Melanoma: A Single-Center Experience”

Case Reports in Oncological Medicine
Oncology
2019English

Guillain-Barré Syndrome

2020French

Guillain–Barré Syndrome: A Century of Progress

Nature Reviews Neurology
Molecular NeuroscienceNeurologyCellular
2016French

Physical Therapy and Functional Motor Recovery in Patient With Guillain-Barré Syndrome - Case Report

European Scientific Journal, ESJ
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy